TG Therapeutics, Inc.
TGTX
Jodie situation report
TG Therapeutics, Inc.'s current read is isolated; its market group is not confirming.
The latest filing is mixed. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.
- Revenue increased 70.3% versus the comparable filing period.
- Operating margin fell 15.7 percentage points.
- R&D expense tripled in the three months, with management citing subcutaneous manufacturing work and higher clinical-trial costs.
- April 2026 executive order seeks up to a 100% tariff on imported patented pharmaceutics, with exceptions for MFN pricing agreements or onshore manufacturing.
Invalidation: The isolated read changes if TGTX's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind TGTX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
OWLBlue Owl Capital Inc.lenderMay 6, 2026 ▾
“Financial Update In March 2026, we entered into a new five-year, $750 million senior secured credit facility with funds managed by Blue Owl Capital.”
NVSNovartis AGcompetitorFeb 27, 2026 ▾
“In addition, BRIUMVI competes with ofatumumab (Novartis AG), a patient/self-administered subcutaneous anti-CD20 monoclonal antibody approved for MS.”
HTGCHercules Capital, Inc.lenderFeb 27, 2026 ▾
“The $11.4 million increase is mainly due to $4.6 million of debt extinguishments costs incurred pertaining to the prior loan agreement with Hercules as well as increased interest expense pertaining to the Initial Term Loan with Blue Owl during the same period…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
TGTX is currently a Leader in the organic co-movement group Anti-CD20 MS Therapies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for TGTX; it is not active in the latest market snapshot.